Hexachlorophene decisions at the FDA.
D003428:Cross Infection / Q000517:prevention & control; D006582:Hexachlorophene / Q000009:adverse effects* / Q000097:blood / Q000378:metabolism / Q000627:therapeutic use; D006801:Humans; D007231:Infant, Newborn; D007232:Infant, Newborn, Diseases / Q000517:prevention & control*; D010564:Personnel, Hospital; D012869:Skin Absorption; D013203:Staphylococcal Infections / Q000453:epidemiology / Q000517:prevention & control*; D014481:United States; D014486:United States Food and Drug Administration
D006582:Hexachlorophene